Citation: Dexuan Xiao, Tianyu Chen, Tianxu Zhang, Sirong Shi, Mei Zhang, Xin Qin, Yunkun Liu, Longjiang Li, Yunfeng Lin. Transdermal treatment for malignant melanoma by aptamer-modified tetrahedral framework nucleic acid delivery of vemurafenib[J]. Chinese Chemical Letters, ;2024, 35(4): 108602. doi: 10.1016/j.cclet.2023.108602 shu

Transdermal treatment for malignant melanoma by aptamer-modified tetrahedral framework nucleic acid delivery of vemurafenib

Dexuan Xiao ^{a, b, c} ,
Tianyu Chen ^{a, b} ,
Tianxu Zhang ^{a, b} ,
Sirong Shi ^{a, b} ,
Mei Zhang ^{a, b} ,
Xin Qin ^{a, b} ,
Yunkun Liu ^{a, c} ,
Longjiang Li ^{a, c, *,} ,
Yunfeng Lin ^{a, b, *,}

a.
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
b.
Sichuan Provincial Engineering Research Center of Oral Biomaterials, Chengdu 610041, China
c.
Department of Head and Neck Oncology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China

muzili63@163.com

yunfenglin@scu.edu.cn

Received Date: 3 April 2023
Revised Date: 21 May 2023
Accepted Date: 23 May 2023
Available Online: 28 May 2023

Figures(4)

Melanoma is one of the most malignant skin tumors, whose high invasion is generally associated with BRAF gene mutation. Although new chemotherapeutic drugs, such as vemurafenib, have been developed to inhibit the growth of melanoma, these drugs are usually administered intravenously or orally, resulting in toxic side effects on major tissues and organs. Tetrahedral framework nucleic acids (tFNAs) are a novel type of DNA nanostructures with excellent biocompatibility and versatility which have been proven to penetrate through skin barrier with ease. In this study, we prepared tFNAs with vemurafenib and connected DNA aptamer AS1411 at the apex of tFNAs (AS1411-tFNAs/vemurafenib). On one hand, AS1411-tFNAs/vemurafenib could kill melanoma cells by blocking the mutated BRAF gene in vitro. Compared with free vemurafenib, AS1411-tFNAs/vemurafenib had no obvious toxicity to normal cells. On the other hand, AS1411-tFNAs could transfer vemurafenib to cross through the skin barrier and permeate into tumor tissues. In vivo, transdermal delivery of AS1411-tFNAs/vemurafenib could inhibit the growth of human A375 melanoma, whose inhibiting effect was stronger than intravenous administration of vemurafenib. These results demonstrated the application prospects of tFNAs combined with chemotherapeutic drugs in skin tumors.
- Melanoma,
- Vemurafenib,
- DNA nanostructure,
- Transdermal treatment,
- Side effect
1. [1]
  D. Schadendorf, D.E. Fisher, C. Garbe, et al., Nat. Rev. Dis. Primers 1 (2015) 15003. doi: 10.1038/nrdp.2015.3
2. [2]
  P. Dietrich, S. Kuphal, T. Spruss, et al., Oncogene 37 (2018) 897–911. doi: 10.1038/onc.2017.391
3. [3]
  H. Sung, J. Ferlay, R.L. Siegel, et al., CA Cancer J. Clin. 71 (2021) 209–249. doi: 10.3322/caac.21660
4. [4]
  A. Jemal, S.S. Devesa, P. Hartge, et al., J. Natl. Cancer Inst. 93 (2001) 678–683. doi: 10.1093/jnci/93.9.678
5. [5]
  C.M. Balch, J.E. Gershenwald, S.J. Soong, et al., J. Clin. Oncol. 27 (2009) 6199–6206. doi: 10.1200/JCO.2009.23.4799
6. [6]
  S. Carr, C. Smith, J. Wernberg, Surg. Clin. North. Am. 100 (2020) 1–12. doi: 10.1016/j.suc.2019.09.005
7. [7]
  M.B. Atkins, J. Hsu, S. Lee, et al., J. Clin. Oncol. 26 (2008) 5748–5754. doi: 10.1200/JCO.2008.17.5448
8. [8]
  L. Finn, S.N. Markovic, R.W. Joseph, BMC Med. 10 (2012) 23. doi: 10.1186/1741-7015-10-23
9. [9]
  K.T. Flaherty, F.S. Hodi, B.C. Bastian, Curr. Opin. Oncol. 22 (2010) 178–183. doi: 10.1097/CCO.0b013e32833888ee
10. [10]
  H. Davies, G.R. Bignell, C. Cox, et al., Nature 417 (2002) 949–954. doi: 10.1038/nature00766
11. [11]
  M. Colombino, M. Capone, A. Lissia, et al., J. Clin. Oncol. 30 (2012) 2522–2529. doi: 10.1200/JCO.2011.41.2452
12. [12]
  A. De Luca, M.R. Maiello, A. D'alessio, et al., Expert Opin. Ther. Targets 16 Suppl. 2 (2012) S17–S27.
13. [13]
  J.A. Sosman, K.B. Kim, L. Schuchter, et al., N. Engl. J. Med. 366 (2012) 707–714. doi: 10.1056/NEJMoa1112302
14. [14]
  P.B. Chapman, A. Hauschild, C. Robert, et al., N. Engl. J. Med. 364 (2011) 2507–2516. doi: 10.1056/NEJMoa1103782
15. [15]
  E.K. Spengler, D.E. Kleiner, R.J. Fontana, Hepatology 65 (2017) 745–748. doi: 10.1002/hep.28692
16. [16]
  V. Launay-Vacher, S. Zimner-Rapuch, N. Poulalhon, et al., Cancer 120 (2014) 2158–2163. doi: 10.1002/cncr.28709
17. [17]
  D.S. Bernardi, C. Bitencourt, D.S.C. Da Silveira, et al., Nanomedicine 12 (2016) 2439–2448. doi: 10.1016/j.nano.2016.07.001
18. [18]
  R. Ruan, P. Jin, L. Zhang, et al., Mol. Pharm. 11 (2014) 4015–4022. doi: 10.1021/mp500277g
19. [19]
  Y. Chen, Y. Shen, X. Guo, et al., Nat. Biotechnol. 24 (2006) 455–460. doi: 10.1038/nbt1193
20. [20]
  A. Alexander, S. Dwivedi, Ajazuddin, et al., J. Control. Release 164 (2012) 26–40. doi: 10.1016/j.jconrel.2012.09.017
21. [21]
  A.Z. Alkilani, M.T.C. Mccrudden, R.F. Donnelly, Pharmaceutics 7 (2015) 438–470. doi: 10.3390/pharmaceutics7040438
22. [22]
  V.K. Rai, N. Mishra, K.S. Yadav, et al., J. Control. Release 270 (2018) 203–225. doi: 10.1016/j.jconrel.2017.11.049
23. [23]
  M.R. Prausnitz, R. Langer, Nat. Biotechnol. 26 (2008) 1261–1268. doi: 10.1038/nbt.1504
24. [24]
  P.W.K. Rothemund, Nature 440 (2006) 297–302. doi: 10.1038/nature04586
25. [25]
  T. Tian, T. Zhang, S. Shi, et al., Nat. Protoc. 18 (2023) 1028–1055. doi: 10.1038/s41596-022-00791-7
26. [26]
  T. Tian, Y. Li, Y. Lin, Bone Res. 10 (2022) 40. doi: 10.1038/s41413-022-00212-1
27. [27]
  J. Li, Y. Yao, Y. Wang, et al., Adv. Mater. 34 (2022) e2202513. doi: 10.1002/adma.202202513
28. [28]
  Z. Liu, X. Chen, W. Ma, et al., Adv. Funct. Mater. 32 (2022) 2204587. doi: 10.1002/adfm.202204587
29. [29]
  Y. Wen, M. Zhang, Y. Yao, et al., Chin. Chem. Lett. 34 (2023) 107549. doi: 10.1016/j.cclet.2022.05.063
30. [30]
  Y. Gao, X. Chen, T. Tian, et al., Adv. Mater. 34 (2022) e2201731. doi: 10.1002/adma.202201731
31. [31]
  T. Zhang, H. Ma, X. Zhang, et al., Adv. Funct. Mater. 33 (2023) 2213401. doi: 10.1002/adfm.202213401
32. [32]
  B. Zhang, T. Tian, D. Xiao, et al., Adv. Funct. Mater. 32 (2022) 2109728. doi: 10.1002/adfm.202109728
33. [33]
  S. Li, Y. Liu, T. Zhang, et al., Adv. Mater. 34 (2022) e2204287. doi: 10.1002/adma.202204287
34. [34]
  C. Wiraja, Y. Zhu, D.C.S. Lio, et al., Nat. Commun. 10 (2019) 1147. doi: 10.1038/s41467-019-09029-9
35. [35]
  R. Yan, W. Cui, W. Ma, et al., ACS Nano 17 (2023) 8767–8781. doi: 10.1021/acsnano.3c02102
36. [36]
  M. Zhang, Y. Wen, Z. Huang, et al., Chem. Eng. J. 435 (2023) 134855.
37. [37]
  Y. Wang, W. Jia, J. Zhu, R. Xu, Y. Lin, Chin. Chem. Lett. 34 (2023) 107746. doi: 10.1016/j.cclet.2022.107746
38. [38]
  X. Qin, L. Xiao, N. Li, et al., Bioact. Mater. 14 (2022) 134–144.
39. [39]
  W. Ma, Y. Yang, J. Zhu, et al., Adv. Mater. 34 (2022) e2109609. doi: 10.1002/adma.202109609
40. [40]
  L. Liang, J. Li, Q. Li, et al., Angew. Chem. Int. Ed. 53 (2014) 7745–7750. doi: 10.1002/anie.201403236
41. [41]
  D. Xiao, Y. Li, T. Tian, et al., ACS Appl. Mater. Interfaces 13 (2021) 6109–6118. doi: 10.1021/acsami.0c23005
42. [42]
  L. Li, J. Hou, X. Liu, et al., Biomaterials 35 (2014) 3840–3850. doi: 10.1016/j.biomaterials.2014.01.019
43. [43]
  J.Y. Zhu, M. Zhang, Y. Gao, et al., Signal. Transduct. Target. Ther. 5 (2020) 120. doi: 10.1038/s41392-020-0173-3
44. [44]
  M. Peacock, R. Brem, P. Macpherson, et al., Nucleic Acids Res. 42 (2014) 13714–13722. doi: 10.1093/nar/gku1213
45. [45]
  H. Rajagopalan, A. Bardelli, C. Lengauer, et al., Nature 418 (2002) 934. doi: 10.1038/418934a
46. [46]
  E.W. Joseph, C.A. Pratilas, P.I. Poulikakos, et al., Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 14903–14908. doi: 10.1073/pnas.1008990107
47. [47]
  F. Shen, L. Sun, L. Wang, et al., Nano Lett. 22 (2022) 4509–4518. doi: 10.1021/acs.nanolett.2c01332
1. [1]
  Ling Yang , Min Ren , Jie Wang , Liming He , Shanshan Wu , Shuai Yang , Wei Zhao , Hao Cheng , Xiaoming Zhou , Maling Gou . A non-viral gene therapy for melanoma by staphylococcal enterotoxin A. Chinese Chemical Letters, 2024, 35(5): 108822-. doi: 10.1016/j.cclet.2023.108822
2. [2]
  Jia-Li Xie , Tian-Jin Xie , Yu-Jie Luo , Kai Mao , Cheng-Zhi Huang , Yuan-Fang Li , Shu-Jun Zhen . Octopus-like DNA nanostructure coupled with graphene oxide enhanced fluorescence anisotropy for hepatitis B virus DNA detection. Chinese Chemical Letters, 2024, 35(6): 109137-. doi: 10.1016/j.cclet.2023.109137
3. [3]
  Zhe-Han Yang , Jie Yin , Lei Xin , Yuanfang Li , Yijie Huang , Ruo Yuan , Ying Zhuo . Research advancement of DNA-based intelligent hydrogels: Manufacture, characteristics, application of disease diagnosis and treatment. Chinese Chemical Letters, 2024, 35(10): 109558-. doi: 10.1016/j.cclet.2024.109558
4. [4]
  Yu Qin , Mingyang Huang , Chenlu Huang , Hannah L. Perry , Linhua Zhang , Dunwan Zhu . O₂-generating multifunctional polymeric micelles for highly efficient and selective photodynamic-photothermal therapy in melanoma. Chinese Chemical Letters, 2024, 35(7): 109171-. doi: 10.1016/j.cclet.2023.109171
5. [5]
  Chang Liu , Tao Wu , Lijiao Deng , Xuzi Li , Xin Fu , Shuzhen Liao , Wenjie Ma , Guoqiang Zou , Hai Yang . Programmed DNA walkers for biosensors. Chinese Chemical Letters, 2024, 35(9): 109307-. doi: 10.1016/j.cclet.2023.109307
6. [6]
  Lijun Mao , Shuo Li , Xin Zhang , Zhan-Ting Li , Da Ma . Cucurbit[n]uril-based nanostructure construction and modification. Chinese Chemical Letters, 2024, 35(8): 109363-. doi: 10.1016/j.cclet.2023.109363
7. [7]
  Erzhuo Cheng , Yunyi Li , Wei Yuan , Wei Gong , Yanjun Cai , Yuan Gu , Yong Jiang , Yu Chen , Jingxi Zhang , Guangquan Mo , Bin Yang . Galvanostatic method assembled ZIFs nanostructure as novel nanozyme for the glucose oxidation and biosensing. Chinese Chemical Letters, 2024, 35(9): 109386-. doi: 10.1016/j.cclet.2023.109386
8. [8]
  Zhigang Zeng , Changzhou Liao , Lei Yu . Molecules for COVID-19 treatment. Chinese Chemical Letters, 2024, 35(7): 109349-. doi: 10.1016/j.cclet.2023.109349
9. [9]
  Yu ZHANG , Fangfang ZHAO , Cong PAN , Peng WANG , Liangming WEI . Application of double-side modified separator with hollow carbon material in high-performance Li-S battery. Chinese Journal of Inorganic Chemistry, 2024, 40(6): 1218-1232. doi: 10.11862/CJIC.20230412
10. [10]
  Supphachok Chanmungkalakul , Syed Ali Abbas Abedi , Federico J. Hernández , Jianwei Xu , Xiaogang Liu . The dark side of cyclooctatetraene (COT): Photophysics in the singlet states of “self-healing” dyes. Chinese Chemical Letters, 2024, 35(8): 109227-. doi: 10.1016/j.cclet.2023.109227
11. [11]
  Yang Qin , Jiangtian Li , Xuehao Zhang , Kaixuan Wan , Heao Zhang , Feiyang Huang , Limei Wang , Hongxun Wang , Longjie Li , Xianjin Xiao . Toeless and reversible DNA strand displacement based on Hoogsteen-bond triplex. Chinese Chemical Letters, 2024, 35(5): 108826-. doi: 10.1016/j.cclet.2023.108826
12. [12]
  Xiaohong Wen , Mei Yang , Lie Li , Mingmin Huang , Wei Cui , Suping Li , Haiyan Chen , Chen Li , Qiuping Guo . Enzymatically controlled DNA tetrahedron nanoprobes for specific imaging of ATP in tumor. Chinese Chemical Letters, 2024, 35(8): 109291-. doi: 10.1016/j.cclet.2023.109291
13. [13]
  Jingwen Zhao , Jianpu Tang , Zhen Cui , Limin Liu , Dayong Yang , Chi Yao . A DNA micro-complex containing polyaptamer for exosome separation and wound healing. Chinese Chemical Letters, 2024, 35(9): 109303-. doi: 10.1016/j.cclet.2023.109303
14. [14]
  Jiqing Liu , Qi Dang , Liting Wang , Dejin Wang , Liang Tang . Applications of flexible electrochemical electrodes in wastewater treatment: A review. Chinese Chemical Letters, 2024, 35(8): 109277-. doi: 10.1016/j.cclet.2023.109277
15. [15]
  Ziruo Zhou , Wenyu Guo , Tingyu Yang , Dandan Zheng , Yuanxing Fang , Xiahui Lin , Yidong Hou , Guigang Zhang , Sibo Wang . Defect and nanostructure engineering of polymeric carbon nitride for visible-light-driven CO2 reduction. Chinese Journal of Structural Chemistry, 2024, 43(3): 100245-100245. doi: 10.1016/j.cjsc.2024.100245
16. [16]
  Tong Zhang , Chao Sun , Shubin Yang , Zimin Cai , Sifeng Zhu , Wendian Liu , Yun Luan , Cheng Wang . Inhalation of taraxasterol loaded mixed micelles for the treatment of idiopathic pulmonary fibrosis. Chinese Chemical Letters, 2024, 35(8): 109248-. doi: 10.1016/j.cclet.2023.109248
17. [17]
  Wenhao Chen , Jian Du , Hanbin Zhang , Hancheng Wang , Kaicheng Xu , Zhujun Gao , Jiaming Tong , Jin Wang , Junjun Xue , Ting Zhi , Longlu Wang . Surface treatment of GaN nanowires for enhanced photoelectrochemical water-splitting. Chinese Chemical Letters, 2024, 35(9): 109168-. doi: 10.1016/j.cclet.2023.109168
18. [18]
  Wenlong Li , Feishi Shan , Qingdong Bao , Qinghua Li , Hua Gao , Leyong Wang . Supramolecular assembly nanoparticle for trans-epithelial treatment of keratoconus. Chinese Chemical Letters, 2024, 35(10): 110060-. doi: 10.1016/j.cclet.2024.110060
19. [19]
  Haijing Cui , Weihao Zhu , Chuning Yue , Ming Yang , Wenzhi Ren , Aiguo Wu . Recent progress of ultrasound-responsive titanium dioxide sonosensitizers in cancer treatment. Chinese Chemical Letters, 2024, 35(10): 109727-. doi: 10.1016/j.cclet.2024.109727
20. [20]
  Tian Feng , Yun-Ling Gao , Di Hu , Ke-Yu Yuan , Shu-Yi Gu , Yao-Hua Gu , Si-Yu Yu , Jun Xiong , Yu-Qi Feng , Jie Wang , Bi-Feng Yuan . Chronic sleep deprivation induces alterations in DNA and RNA modifications by liquid chromatography-mass spectrometry analysis. Chinese Chemical Letters, 2024, 35(8): 109259-. doi: 10.1016/j.cclet.2023.109259

Get Citation

PDF

XML

Metrics

PDF Downloads(1)
Abstract views(90)
HTML views(0)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142